Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

$99 Cash Card Program provides 3000-3800 units of any combination of Novo Nordisk analog insulins in vials or pens. NovoLog authorized generics are available at half...
The Medicine Assistance Tool (MAT) is a search engine to help find patient assistance resources for your medications
For now, another SGLT-2 inhibitor pill already approved for people with type 2 diabetes is not approved for people with type 1 diabetes in the US. The drug was recently...
Farxiga’s heart health benefits were the same in people with and without diabetes, as well as across a spectrum of baseline A1C levels
A new premixed, liquid glucagon coming in October in a prefilled syringe and in 2020 as an auto-injector. The second stable glucagon approved this year
By Becky Milner A company called Intarcia has developed a GLP-1 mini-pump that is implanted under the skin to continuously provide medication for six months at a time –...
These new rules will save both consumers and health plan providers thousands of dollars a year through pre-deductible coverage of chronic condition treatments
New guidelines from ADA and EASD focus on GLP-1 agonists and SGLT-2 inhibitors to improve heart and kidney health
Xofluza was recently approved to treat the flu in higher-risk populations – people with diabetes or other chronic conditions, and people over age 65 – and to prevent...
Read on to learn about the research around GLP-1, SGLT-2, and combination therapy use in type 1 diabetes. Dr. Paresh Dandona is a Distinguished Professor and Chief of...
Beginning in 2020, nation-wide Cigna (and Express Scripts) and three Minnesota insurance companies (Blue Cross and Blue Shield, Medica, and UCare) will cap total monthly...
FDA approval the fast-acting insulin for children means that children will have more flexibility in their mealtime insulin dosing
The diaTribe team was in Barcelona for the 55 th Annual Meeting of the European Association for the Study of Diabetes. Check out our biggest highlights from the...
A few weeks ago, Kelly experienced severe hypoglycemia (she left her RileyLink in her basement by accident!) – lucky for her, she had just picked up a new emergency...
As we enter hurricane season, here are three important steps people with diabetes can take to prepare for natural disasters
New updates include the recommendation of GLP-1 agonists and SGLT-2 inhibitors for heart and kidney protection, earlier combination therapy in type 2 diabetes, GLP-1...
Read about the approval of Rybelsus, the first oral GLP-1 agonist, here . “I do think this is a great day for people with diabetes. I do hope that primary care providers...
An oral (pill) version of Ozempic, Rybelsus, becomes the first GLP-1 agonist pill for type 2 diabetes
Will the medication move from “off label” to standard of care for people at high risk of developing type 2 diabetes?
New updates include time-in-range goals, heart health benefits of GLP-1 agonist Trulicity, and recommendation of GLP-1 agonist Victoza for children and teens with type 2...

Pages